Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Cardiac Markers - Making their Mark on the Medicines Market' returned 11 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Cardiac Marker Diagnostic Testing Markets   TriMark Publications, Nov 2011, Pages: 139 people worldwide die from a CVD. This TriMark Publications report describes the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing, including size; growth Multiplexed Diagnostics 2009 Market Report   Select Biosciences Ltd, March 2009, Pages: 492 Metabolic Markers 90 New Development Has Widespread Support 91 Not Everyone Is Convinced of the Value 93 Personalized Medicine Has Started Slowly 94 Healthcare Reform 97 Education 98 Business Models 99 European Point of Care Diagnostic Testing Markets   TriMark Publications, Sep 2011, Pages: 179 , cardiac markers, substance abuse, infectious diseases, urine strip, pregnancy, fecal occult, cholesterol, and many others. For each of the individual sub-segments, this study examines the key market drivers Proteomics - Technologies, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 617 of medicine in the post-genomic era - the first decade of the 21st century. Most commonly used technologies are 2D gel electrophoresis for protein separation and analysis of proteins by mass spectrometry Clinical Laboratory Testing Volume 2: Business Strategies   TriMark Publications, Sep 2010, Pages: 117 .5 Diabetes (Glucose) Testing 4.6 Molecular Diagnostic Testing 4.7 Cardiac Markers 4.8 Blood Bank Screening 4.9 Genetic Testing 4.10 Predictive Medicine Testing 4.11 Personalized Medicine 4.12 Cancer United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others   GlobalData, Aug 2011, Pages: 501 United States Cardiovascular Devices Market Outlook to 2017 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Prosthetic Heart Valves, Electrophysiology and Others North America Cardiovascular Devices Market Outlook to 2017   GlobalData, Aug 2011, Pages: 276 – Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators Biochips - Global Strategic Business Report   Global Industry Analysts, Inc., Feb 2011, Pages: 630 46 Veredus Laboratories Launches Portable Test Kit for H1N1 Flu 46 Randox Develops Multi Marker Cardiac Biochip Array for MI Diagnosis 46 VigeneTech and CapitalBio Launch Completely Integrated General and Applied Toxicology, 6 Volume Set, 3rd Edition   John Wiley and Sons Ltd, Oct 2009, Pages: 3490 and Timothy C. Marrs). 35 Toxicity Data Obtained From Human Studies (Martin F. Wilks and Hugo Kupferschmidt). 36 Significance of Biochemical Markers in Applied Toxicology (Fernando Gil and Antonio F The Executive Guide to Molecular Imaging   Espicom Business Intelligence Ltd, July 2007, Pages: 306 COMPANIES AGENIX ThromboView Recent Highlights ThromboView Market Forecast Divestitures Funding AION DIAGNOSTICS Molecular Imaging Candidate mpSi Pilot Study Results Hybrid Contrast Agent Marking Agent In Vitro Diagnostics - A Global Market Overview   Industry Experts, May 2012, Pages: 493 Conditions IVD and Immunoassays Point-of-Care Technology Evolution of Cardiac Markers POC Immunoassay Platforms: What the Future Holds 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS Abbott and Genetics Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network